The evaluation of airway and/or lung inflammation via a fraction of exhaled nitric oxide

The evaluation of airway and/or lung inflammation via a fraction of exhaled nitric oxide - The evaluation of airway and/or lung inflammation via a fraction of exhaled nitric oxide

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019953

Enrollment

780

Registered

2015-11-27

Start date

2015-11-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory disease

Interventions

mesurements of a fraction of exhaled nitric oxide

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy control and patients suffering from bronchial asthma, COPD, interstitial pneumonia, drug induced lung disease, lung cancer, radiation pneumonia, acute pneumonia, bronchiectasis and sarcoidosis.

Exclusion criteria

Exclusion criteria: patients with hemoptysis

Design outcomes

Primary

Measure	Time frame
correlation between exhaled nitric oxide and several parameters	—

Countries

Japan

Contacts

Public ContactKeiko Wakahara

Nagoya University respiratory medicine

wakahara@med.nagoya-u.ac.jp0527442167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026